Advertisement
Canada markets closed
  • S&P/TSX

    21,947.41
    +124.19 (+0.57%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CAD/USD

    0.7308
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • Bitcoin CAD

    86,291.20
    +5,315.03 (+6.56%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • NASDAQ

    16,156.33
    +315.37 (+1.99%)
     
  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6787
    -0.0030 (-0.44%)
     

Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings

Encompass Health (EHC) reported $1.32 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 13.4%. EPS of $1.12 for the same period compares to $0.88 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.27 billion, representing a surprise of +3.60%. The company delivered an EPS surprise of +20.43%, with the consensus EPS estimate being $0.93.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net patient revenue per discharge: $20,990 compared to the $20,895.64 average estimate based on two analysts.

  • Total Discharges: 61,111 versus the two-analyst average estimate of 59,601.

  • Revenues- Inpatient Rehabilitation: $1.28 billion versus $1.25 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.

  • Revenues- Outpatient and other: $33.30 million versus $27.56 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +27.1% change.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned +7.5% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Encompass Health Corporation (EHC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research